NewsRoom Articles - Page 107 of 154 - PsychedelicNewsWire (PNW)

TuesdayFeb 16, 2021 1:30 pm

Cambridge City Councilors Approve Psychedelics Decriminalization Measure

A Massachusetts city may soon be decriminalizing the possession and use of most psychedelics and entheogenic plants. City councilors in Cambridge, Massachusetts, recently approved the policy order, which will also decriminalize all controlled substances. The order was sponsored by Councilor Jivan Sobrinho-Wheeler. Wheeler stated that research had shown that psychedelic fungi and plants, such as psilocybin mushrooms, could be used to treat various substance use and mental health issues. The initiative directed the manager of Cambridge City to cooperate with state and federal partners to decriminalize psychedelics, which are currently classified as controlled substances, in addition to being illegal under…

FridayFeb 12, 2021 11:00 am

New Jersey Gov Signs Bill Reclassifying Psilocybin

Gov. Phil Murphy of New Jersey recently signed a psilocybin reform measure that reclassified possession of up to one ounce of psilocybin mushrooms under a disorderly persons’ offense. This reclassification means that persons caught with small amounts of psilocybin will be subject to up to six months in jail, a $1000 fine or both. The offense was previously punishable with fines of up to $15 000 and a penalty of three to five years in jail, and was considered a third-degree crime. This change puts psilocybin mushroom possession in the state on par with resisting arrest, shoplifting, harassment or simple…

ThursdayFeb 11, 2021 2:15 pm

Progressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients

Dr. Hyder Khoja is hoping to use psychedelics to treat patients in comas in a bid to stimulate them back into consciousness. Psychedelics have the potential to treat various mental conditions, with more uses still being discovered. There are roughly 59 clinical trials registered around the world that plan on using psilocybin to manage mental health conditions. While a majority of these clinical trials are focusing on mental ailments such as OCD, anxiety and depression, Khoja intends to use these powerful substances to jump-start consciousness in unresponsive patients in comas. Khoja, who received his molecular biology and genetic engineering PhD…

WednesdayFeb 10, 2021 2:45 pm

War Hero from Ontario Featured in Psychedelic Documentary

A documentary focusing on the area of psychedelic drugs as a potential treatment for mental-health issues. The documentary features several individuals who share their experiences and feelings regarding psychedelics. In the documentary, area war hero Patrick Moulden noted that he is taking a chance on psychedelics in a bid to help manage his mental distress. Russell Peters, a comedian who recently joined a psychedelic firm based in Canada, stated that there were a lot of individuals who suffered from depression, adding that he was one of them. World-renowned addiction specialist Dr. Evan Wood says that psychedelics had enough potential to…

TuesdayFeb 09, 2021 2:30 pm

Should Montreal Expect Psychedelic Revolution in the Near Future? Activists Think So

Health Canada granted five legal exemptions since August last year to Canadians who had requested access to magic mushroom therapy for both serious mental trauma and end-of-life care. In December, the body had announced that it would be revising its Special Access Program, which would make it easy for individuals (special cases) to access psychedelics. Montreal Psychedelic Society executive director Jessica Cadoch stated in an interview that when the book “How to Change Your Mind” by Michael Pollan came out, momentum on psychedelics increased rapidly. The book, which focuses on the science of psychedelics, was released in 2018, the same…

MondayFeb 08, 2021 2:00 pm

Connecticut, Florida Legislators File Psychedelic Mushroom Bills

Legislators in Florida and Connecticut have filed new measures to reform state legislations on psychedelic mushrooms. Rep. Michael Grieco filed a bill in Florida last week. The legislation would establish the legal therapeutic use of psilocybin in the state, which is similar to a measure that voters in Oregon passed in November 2020. The main goal of Florida’s initiative is to promote the treatment of various mental health conditions with the help of psilocybin. In addition, Florida’s measure would deprioritize the criminal enforcement of various psychedelic fungi and plants. Florida’s initiative states that psilocybin has demonstrated safety, tolerability and efficacy…

FridayFeb 05, 2021 1:30 pm

Experts Predict What 2021 Psychedelics Space Might Look Like

Psychedelics went mainstream last year, with more than 20 firms in the psychedelics industry getting listed publicly. The industry has also moved forward with regard to federal legalization, with some substances having received breakthrough therapy designations from the FDA. Many are excited to see what big things are in store for the young industry. Canopy Growth Corp.'s (TSX: WEED) (NYSE: CGC) founder and former CEO Bruce Linton stated that he expected that by this year’s end, the conversation on accessing psychedelic therapy will be global. He remarked that this year would start a proper conversation on psychedelic medicine. Linton, who…

ThursdayFeb 04, 2021 11:30 am

New Hawaii Senate Bill May See Psilocybin Mushroom Therapy Legalized

Hawaii may soon be the next state to legalize the use of psilocybin mushrooms if a bill, known as SB 738, that was recently filed in the state legislature is approved. According to SB 738, the state’s Department of Health would be directed to set up designated centers of treatment, where psilocin and psilocybin will be administered therapeutically. The two psychoactive compounds are produced by fungi from the genus Psilocybe. The measure’s approval would also lead to the creation of a seven-person panel for psilocybin review that would evaluate the influence of the change in policy, while also facilitating the…

WednesdayFeb 03, 2021 2:56 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Updates Investors Following Completion of Special Warrants Private Placement

Pure Extracts recently updated investors on successful completion of second tranche of its special warrants private placement In aggregate, Company will raise gross proceeds of $8.5 million through both tranches of private placement Pure Extracts will employ net proceeds from private placement towards capacity expansion for Company’s extraction business, and for general working capital purposes Company previously revealed that it was conducting study looking into formulation, manufacturing of psilocybin-based active treatments Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has recently updated investors following the successful…

TuesdayFeb 02, 2021 3:35 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Is ‘One to Watch’

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities The company has research and development operations in North America and Europe and an operational focus in Germany XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19 XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications;…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000